Latest Regulatory Clearance News

Forrestania Resources has agreed to acquire MacPhersons Reward, consolidating its Coolgardie gold tenure with a $5 million cash and share deal that supports its shift from explorer to near-term producer.

Genesis Minerals Limited has announced a recommended scheme to acquire Magnetic Resources NL, bringing a high-grade 2.2 million ounce gold resource near its Laverton mill and offering Magnetic shareholders a compelling premium with a mix of cash and shares.

Ramsay Health Care has cleared a major regulatory hurdle with ACCC approval to acquire National Capital Private Hospital, setting the stage for completion in early fiscal 2027.

ADX Energy has restarted flow testing at its Welchau-1 well in Austria after regulatory delays, aiming to confirm the commercial viability of light oil and gas-condensate reservoirs in the Reifling Formation.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.

Strategic Energy Resources Limited is set to consolidate its shares on a 1-for-20 basis, significantly reducing the number of shares on issue and adjusting option exercise prices. The move, effective from April 1, 2026, follows all necessary approvals and aims to streamline the company’s capital structure.

BlinkLab has expanded its pivotal FDA 510(k) autism diagnostic trial to nine top U.S. sites, adding Drexel University ahead of the Q1 2026 study start. This move follows a successful pilot study that exceeded FDA benchmarks, positioning BlinkLab Dx 1 for regulatory clearance.

National Storage REIT delivered robust half-year results with earnings and occupancy gains, while agreeing to a premium acquisition offer from Brookfield-GIC consortium.

SGH Limited has announced a fully franked ordinary dividend of AUD 0.32 per share for the six months ending December 2025, signalling steady returns for shareholders.

Memphasys Limited has secured Therapeutic Goods Administration approval for its Felix™ System two months ahead of schedule, enabling immediate commercial sales and clinical use in Australia.

Aurora Energy Metals updates investors on its strategic option agreement with Eagle Energy Metals, which is set to become the first US-listed uranium explorer with SMR technology following a pending SPAC merger.

Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.